Karrie L. Jones

1.5k total citations
20 papers, 1.2k citations indexed

About

Karrie L. Jones is a scholar working on Immunology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Karrie L. Jones has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Karrie L. Jones's work include Nuclear Receptors and Signaling (8 papers), Macrophage Migration Inhibitory Factor (7 papers) and Telomeres, Telomerase, and Senescence (5 papers). Karrie L. Jones is often cited by papers focused on Nuclear Receptors and Signaling (8 papers), Macrophage Migration Inhibitory Factor (7 papers) and Telomeres, Telomerase, and Senescence (5 papers). Karrie L. Jones collaborates with scholars based in United States, Japan and France. Karrie L. Jones's co-authors include Dennis Bruemmer, Elizabeth B. Heywood, Florence Gizard, Takashi Nomiyama, Hannes M. Findeisen, Ryuzo Kawamori, Hua Qing, Yue Zhao, Dianne Cohn and Yue Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Karrie L. Jones

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karrie L. Jones United States 15 513 353 310 260 259 20 1.2k
Elizabeth B. Heywood United States 15 505 1.0× 390 1.1× 298 1.0× 257 1.0× 266 1.0× 22 1.2k
Emilie Distel France 12 483 0.9× 194 0.5× 588 1.9× 398 1.5× 108 0.4× 15 1.5k
He Wu China 20 601 1.2× 144 0.4× 203 0.7× 321 1.2× 73 0.3× 46 1.6k
Martine Bot Netherlands 16 534 1.0× 214 0.6× 478 1.5× 109 0.4× 74 0.3× 23 1.1k
Fei Fang China 22 832 1.6× 149 0.4× 272 0.9× 256 1.0× 97 0.4× 66 1.5k
Xiaohe Luo China 14 393 0.8× 268 0.8× 160 0.5× 164 0.6× 64 0.2× 29 863
Stephan Goetze Germany 22 1.3k 2.6× 362 1.0× 252 0.8× 242 0.9× 83 0.3× 38 2.1k
Yuichi Oshima Japan 17 1.1k 2.1× 372 1.1× 231 0.7× 316 1.2× 51 0.2× 21 2.0k
Ghi Su Kim South Korea 22 723 1.4× 185 0.5× 122 0.4× 132 0.5× 60 0.2× 45 1.5k
Michèle Geoffrion Canada 16 1.1k 2.1× 213 0.6× 493 1.6× 266 1.0× 103 0.4× 33 1.8k

Countries citing papers authored by Karrie L. Jones

Since Specialization
Citations

This map shows the geographic impact of Karrie L. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karrie L. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karrie L. Jones more than expected).

Fields of papers citing papers by Karrie L. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karrie L. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karrie L. Jones. The network helps show where Karrie L. Jones may publish in the future.

Co-authorship network of co-authors of Karrie L. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Karrie L. Jones. A scholar is included among the top collaborators of Karrie L. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karrie L. Jones. Karrie L. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jinghui, Daheng He, Lijun Cheng, et al.. (2020). p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer. Oncogene. 39(19). 3939–3951. 85 indexed citations
2.
Wu, Tongzhi, Michael Horowitz, Karrie L. Jones, & Christopher K. Rayner. (2017). Endogenous glucagon-like peptide-1 mediates the lowering of glycaemia during small intestinal glucose infusion by bile acids in type 2 diabetes. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2 indexed citations
3.
Qing, Hua, Karrie L. Jones, Elizabeth B. Heywood, et al.. (2017). Deletion of the NR4A nuclear receptor NOR1 in hematopoietic stem cells reduces inflammation but not abdominal aortic aneurysm formation. BMC Cardiovascular Disorders. 17(1). 271–271. 13 indexed citations
4.
Aono, Jun, Hua Qing, Hannes M. Findeisen, et al.. (2016). Telomerase Inhibition by Everolimus Suppresses Smooth Muscle Cell Proliferation and Neointima Formation Through Epigenetic Gene Silencing. JACC Basic to Translational Science. 1(1-2). 49–60. 7 indexed citations
5.
Qing, Hua, Jun Aono, Naoto Terami, et al.. (2016). Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes. Arteriosclerosis Thrombosis and Vascular Biology. 37(2). 301–311. 14 indexed citations
6.
Qing, Hua, Jun Aono, Hannes M. Findeisen, et al.. (2015). Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition. Journal of Cellular Physiology. 231(6). 1276–1282. 12 indexed citations
7.
Zhao, Yue, Takashi Nomiyama, Hannes M. Findeisen, et al.. (2014). Epigenetic regulation of the NR4A orphan nuclear receptor NOR1 by histone acetylation. FEBS Letters. 588(24). 4825–4830. 8 indexed citations
8.
Qing, Hua, Yi Liu, Yue Zhao, et al.. (2014). Deficiency of the NR4A Orphan Nuclear Receptor NOR1 in Hematopoietic Stem Cells Accelerates Atherosclerosis. Stem Cells. 32(9). 2419–2429. 27 indexed citations
9.
Gizard, Florence, Yue Zhao, Hannes M. Findeisen, et al.. (2011). Transcriptional Regulation of S Phase Kinase-associated Protein 2 by NR4A Orphan Nuclear Receptor NOR1 in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 286(41). 35485–35493. 25 indexed citations
10.
Findeisen, Hannes M., Kevin J. Pearson, Florence Gizard, et al.. (2011). Oxidative Stress Accumulates in Adipose Tissue during Aging and Inhibits Adipogenesis. PLoS ONE. 6(4). e18532–e18532. 81 indexed citations
11.
Findeisen, Hannes M., Florence Gizard, Yue Zhao, et al.. (2011). Glutathione Depletion Prevents Diet‐Induced Obesity and Enhances Insulin Sensitivity. Obesity. 19(12). 2429–2432. 36 indexed citations
12.
Findeisen, Hannes M., Florence Gizard, Yue Zhao, et al.. (2011). Epigenetic Regulation of Vascular Smooth Muscle Cell Proliferation and Neointima Formation by Histone Deacetylase Inhibition. Arteriosclerosis Thrombosis and Vascular Biology. 31(4). 851–860. 109 indexed citations
13.
Zhao, Yue, Deborah A. Howatt, Florence Gizard, et al.. (2010). Deficiency of the NR4A Orphan Nuclear Receptor NOR1 Decreases Monocyte Adhesion and Atherosclerosis. Circulation Research. 107(4). 501–511. 70 indexed citations
14.
Findeisen, Hannes M., Florence Gizard, Yue Zhao, et al.. (2010). Telomerase Deficiency in Bone Marrow–Derived Cells Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm Formation. Arteriosclerosis Thrombosis and Vascular Biology. 31(2). 253–260. 20 indexed citations
15.
Gizard, Florence, Elizabeth B. Heywood, Hannes M. Findeisen, et al.. (2010). Telomerase Activation in Atherosclerosis and Induction of Telomerase Reverse Transcriptase Expression by Inflammatory Stimuli in Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 31(2). 245–252. 78 indexed citations
16.
Nomiyama, Takashi, Yue Zhao, Florence Gizard, et al.. (2009). Deficiency of the NR4A Neuron-Derived Orphan Receptor-1 Attenuates Neointima Formation After Vascular Injury. Circulation. 119(4). 577–586. 67 indexed citations
17.
Gizard, Florence, Takashi Nomiyama, Yue Zhao, et al.. (2008). The PPARα/p16 INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle–Dependent Telomerase Activation. Circulation Research. 103(10). 1155–1163. 52 indexed citations
18.
Nomiyama, Takashi, Florence Gizard, Elizabeth B. Heywood, et al.. (2007). PPARα Agonists Suppress Osteopontin Expression in Macrophages and Decrease Plasma Levels in Patients With Type 2 Diabetes. Diabetes. 56(6). 1662–1670. 67 indexed citations
19.
Nomiyama, Takashi, Diego Pérez–Tilve, Daisuke Ogawa, et al.. (2007). Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. Journal of Clinical Investigation. 117(10). 2877–2888. 316 indexed citations
20.
Nomiyama, Takashi, Florence Gizard, Elizabeth B. Heywood, et al.. (2006). The NR4A Orphan Nuclear Receptor NOR1 Is Induced by Platelet-derived Growth Factor and Mediates Vascular Smooth Muscle Cell Proliferation. Journal of Biological Chemistry. 281(44). 33467–33476. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth B. Heywood Breakdown of academic impact, for papers by Emilie Distel Breakdown of academic impact, for papers by He Wu Breakdown of academic impact, for papers by Martine Bot Breakdown of academic impact, for papers by Fei Fang Breakdown of academic impact, for papers by Xiaohe Luo Breakdown of academic impact, for papers by Stephan Goetze Breakdown of academic impact, for papers by Yuichi Oshima Breakdown of academic impact, for papers by Ghi Su Kim Breakdown of academic impact, for papers by Michèle Geoffrion
Rankless by CCL
2026